1. Nicotine e-vaping and cardiovascular consequences: a case series and literature review
- Author
-
Sherif Sultan, Maryam Jessri, Ahmed S. Sultan, Niamh Hynes, and Emad Magdy
- Subjects
Cardiovascular toxicity ,Nicotine ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Arterial disease ,Pulmonary effects ,030204 cardiovascular system & hematology ,Lung injury ,03 medical and health sciences ,0302 clinical medicine ,Cigarette smoking ,Case report ,Vaping ,medicine ,Case Series ,AcademicSubjects/MED00200 ,030212 general & internal medicine ,Intensive care medicine ,Electronic nicotine delivery systems ,business.industry ,Cardiovascular consequences ,e-Cigarettes ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Background Cardiovascular toxicity as a consequence of nicotine from conventional tobacco cigarette smoking is well documented. However, little is known about the cardiovascular consequences of nicotine e-vaping. We review the literature and report a case series of three cases of major adverse cardiovascular clinical effects post nicotine e-vaping. Case summary Three patients with known peripheral arterial disease who switched from heavy cigarette smoking consumption to a high-intensity dose of nicotine e-vaping all developed further arterial complications within 6–30 months. Discussion With the recent epidemic of e-vaping in young individuals and the national outbreak of e-vaping use-associated lung injury (EVALI), the dangers of e-vaping are now coming to light. The pulmonary effects are now well described, and this paper highlights three new cases of cardiovascular toxicity associated with e-vaping. The potential role of nicotine e-vaping and the risk of coronavirus disease-2019 (COVID-19) will also be discussed.
- Published
- 2020
- Full Text
- View/download PDF